Recent Headlines
Within Pharmaceuticals
Stevens Thomas Dabay to Present at National Conference on Undergraduate Research
Stevens Institute of Technology student Thomas Dabay ‘11 (Roanoke, Va.) has been selected from among 3,500 applicants to present at the National Conference on Undergraduate Research 2011 (NCUR 2011) at Ithaca College in Ithaca, New York. An Electrical Engineering student, Thomas will present "Absurd America: Finding Camus' Absurd in Pynchon’s America." - February 09, 2011 - Stevens Institute of Technology
Apogen for Anti-Virus, New Dietary Supplement by FEBICO
FEBICO invested almost 10 years of R&D in the self cultivation of their organic spirulina FEM101 to extract the purest water soluble Apogen microalgae protein. In a research collaborated with the Graduate Institute of Biomedical Sciences of Chang Gung University in 1999, they found that the... - February 08, 2011 - Far East Bio-Tech Co., Ltd
ChiroSolve, Inc. Launches New Method Development Kits
ChiroSolve announces the introduction of two new product packages, EnantioPrep and ScalePrep. - February 06, 2011 - ChiroSolve, Inc.
UK Based Diagnostic Company, Randox, Expand Their Portfolio to Meet Demand for Forensic Drug Testing
As drug abuse and drug related crimes continue to prevail, expert forensic analysis is fundamental to the justice process. Global diagnostic company Randox Laboratories has released a number of new products for drug testing in public and private laboratories worldwide. - February 06, 2011 - Randox Laboratories
Colorado's Bioscience Discovery Evaluation Grant Program Creates 598 New Jobs in the State, with Payroll Exceeding $44 million
The Colorado BioScience Association (CBSA) and The Colorado Office of Economic Development and International Trade (OEDIT) have jointly released results of the Bioscience Discovery Evaluation Grant Program (BDEGP) at the CBSA's Third Annual "Bioscience Day at the Capitol" event. The BDEGP was created by the Colorado General Assembly in 2006 to grow the bioscience industry in the state. - February 05, 2011 - Colorado BioScience Association
CCC Diagnostics Inc Announces Expanded Insurance Coverage for the DirectHit Panel for Breast Cancer
CCC Diagnostics Inc has received expanded insurance coverage for the DirectHit Panel for Breast cancer. This expanded coverage includes CareFirst BlueCross/Blue Shield, WellPoint Unicare Networks, CMS Highmark Medicare Services and AmeriGroup. - February 04, 2011 - CCC Diagnostics LLC
Village Fertility Pharmacy’s "Village Voices" Creates Forum for People Affected by Infertility
Those who share journeys, comment on stories in February will be given a chance to win. - February 04, 2011 - Village Fertility Pharmacy
Oncolytics Biotech® Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study
Oncolytics Biotech Inc. (“Oncolytics”) announced that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of... - February 04, 2011 - Oncolytics Biotech
Pacific Biomarkers Names Sheri’ DuMond as Its New Director of Business Development
Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has promoted Sheri’ DuMond to Director of Business Development following her role as Senior Associate Director of Business Development at... - February 04, 2011 - Pacific Biomarkers Inc
CDC Awards Contract to PharmaJet for Development of Needle‐free Intradermal Vaccine Delivery Device
Funding advances development of needle‐free injector that enables reduced doses and antigen‐sparing of vaccines. - February 03, 2011 - PharmaJet, Inc.
Stevens Physics Professor Stefan Strauf Receives NSF CAREER Award for Quantum Research
Dr. Stefan Strauf, Assistant Professor of Physics and Engineering Physics at Stevens Institute of Technology, has been honored by the National Science Foundation with the prestigious CAREER Award. The objective of Dr. Strauf's awarded research is to address the problem of scalability of semiconductor quantum photonic devices, which are currently limited by the inherently random nucleation process of self-assembled quantum dots. - February 03, 2011 - Stevens Institute of Technology
Toxic Metals in Pet Food
An informative Webinar is scheduled for February 10th, to review the findings of an analytical study by SPEX CertiPrep on the levels of toxic metal found in some commercial pet foods. - February 03, 2011 - SPEX CertiPrep Inc
Source-Omega Joins GOED Committee and Features Pure One DHA + EPA Algae Oil
Source-Omega and its Pure One™ branded products are featured on the website of the Global Organization for EPA and DHA Omega-3s (GOED). The company manufactures and markets Pure One™, the first and only US made Optimized Omega-3 DHA + EPA algae oil supplement formulation sold as a... - February 02, 2011 - Source-Omega
Searchable Proposition 65 Chemical Database Released by Columbia Analytical
Columbia Analytical Services, Inc. announces a new website service that allows users to search the California Proposition 65 (Prop 65) chemical list online. The database of 775 chemicals is searchable by a CAS registry number or by the chemical name and when clicked, shows the risk level, maximum... - February 02, 2011 - Columbia Analytical Services
World's Largest Gathering of Stem Cell Patients to be Held in Naples Florida This Saturday
Regenocyte Therapeutic, a worldwide leader in adult stem cell therapy, is hosting an appreciation luncheon for more than 35 of its patients this Saturday – the largest-ever gathering of people treated with adult stem cells. What: Regenocyte Stem Cell Patient Luncheon When: Saturday, January... - January 29, 2011 - Regenocyte Therapeutic
L-Arginine Complete Fights Heart Disease with Nitric Oxide
LArginine-Complete.com, the largest manufacturer of potent, discount L-Arginine Nitric Oxide Supplements, announces its Friends Live Longer Rewards Program. For clients who are health conscious, and know the benefits provided by L-Arginine and Nitric Oxide. - January 28, 2011 - L-Arginine Complete
Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of Directors
Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA). Schniepp has enjoyed a long and productive relationship with the PDA. In addition to serving on numerous committees and being... - January 28, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
New Lin28 Antibody Announced by Novus Biologicals
Novus' new Lin28 antibody is useful for immunofluorescence, immunohistochemistry and Western blot. By Western blot, Lin28 antibodies recognize a band at approximately 29kDa. This new Lin28 antibody was validated by Western blot on NTERA-2 cell lysate and 293T cells overexpressing LIN28. - January 26, 2011 - Novus Biologicals
Local Business Teams Up with Expert Physicians to Help Michigan Families Affected by Autism
On February 12, 2011-- Michigan-based Health Dimensions Compounding Pharmacy is joining forces with five local experts on biomedical autism treatments for a one day only event that aims to educate those affected by autism on bio-medical options. - January 26, 2011 - Health Dimensions Compounding Pharmacy
Advanced Quality & Regulatory Symposium: FDA Speaker & Leading Industry Experts Discuss Compliance Issues in the Drug, Device and Biologics Industry
The 2011 Advanced Quality and Regulatory Symposium for the Biotech and Medical Devices Industry Conference will address the latest regulatory requirements for the development of clinical trials, regulatory submission, and quality systems regulatory requirements for devices, drugs and biologics products. - January 25, 2011 - Monarch Quality Systems Solutions, LLC.
TransEnterix Lands Surgical Device Executive to Serve as Chief Technology Officer
Richard M. Mueller will oversee all aspects of company’s research and development, including rapid innovation. - January 24, 2011 - TransEnterix
AnaSpec Introduces Industry’s First Fluorimetric Assay - SensoLyte® Cathepsin G Kits
AnaSpec, Eurogentec Group, is pleased to announce the release of the industry's first fluorimetric kits for Cathepsin G, the SensoLyte® 520 Cathepsin G Assay Kit and SensoLyte® Rh110 Cathepsin G Assay Kit. These long-wavelength, homogeneous assays are ideal for the screening of enzyme... - January 22, 2011 - AnaSpec, EGT Group
AnaSpec Offers PEGylated Amino Acids
AnaSpec, Eurogentec Group, is pleased to highlight their wide collection of Fmoc- and Boc-protected PEGylated amino acids for PEGylated peptides synthesis. PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple... - January 22, 2011 - AnaSpec, EGT Group
Pixcelldata Presents Collibio Desktop for Digital Pathology
Pixcelldata announces the release of a desktop version of Collibio, next generation software for digital pathology. Collibio allows collaboration between users of proprietary digital scanner systems and their images. Having released Collibio as a web application in October 2010, Pixcelldata have... - January 22, 2011 - Pixcelldata Ltd
CCC Diagnostics, Inc Awarded Qualifying Therapeutic Discovery Project Grant
CCC Diagnostics Inc. has been awarded a Qualifying Therapeutic Discovery Project grant. This grant was awarded to further development and commercialization of the DirectHitTM Test Panel for Breast Cancer. DirectHit is a vastly improved diagnostic test for breast cancer treatment that accurately predicts the tumor’s response to four commonly prescribed classes of anti-cancer drugs. - January 21, 2011 - CCC Diagnostics LLC
OSO BioPharmaceuticals Taps Craig Mastenbaum to Lead West Coast Business Development
OSO BioPharmaceuticals Manufacturing, LLC, has named Craig Mastenbaum director of new business development for its West Coast market. Mastenbaum brings to OsoBio more than 30 years of leadership experience in clinical and contract liquid, lyophilized, ampule and syringe product manufacturing. Most... - January 21, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
MenScience Attacks Stress-Induced Acne During Stress Awareness Month
MenScience Acne Products Treat and Repair Stress-Induced Acne - January 21, 2011 - MenScience Androceuticals
Sustainable Now Technologies Appoints Ryan Dibble as Chief Financial Officer
Sustainable Now Technologies (SNT), a green technologies developer located in Signal Hill, California, has announced today the appointment of Ryan Dibble as Chief Financial Officer. - January 21, 2011 - Sustainable Now Technologies
DrNewtons.com Launches All New Weight Loss Technology: Diabetic-Friendly SKINNY D
DrNewtons.com teams with Bruce Agin, M.D. to distribute a Diabetic-Friendly Meal Replacement Drink. It is proven to increase Protein, Vitamin, and Energy Levels -- versus starve the body -- all at Only 10 Calories per serving. - January 20, 2011 - Dr. Newton's Naturals
Foamix Announces Phase II Clinical Trial of Topical Minocycline Foam for Rosacea
The first-in-class topical Minocycline product, protected by 4 patent applications, is directed for the treatment of Rosacea, Acne, Skin Infections and Chronic Wounds - January 20, 2011 - Foamix Ltd
New Liquid Haptoglobin Assay for the RX Series
The new liquid stable Haptoglobin kit from Randox provides a highly sensitive and specific method for the quantitative determination of Haptoglobin in human serum. The method is fully automated and suitable for use on the RX series of bench top clinical analysers including the RX daytona and RX imola. - January 20, 2011 - Randox Laboratories
Mitegen Appoints New CEO
Mitegen LLC (“Mitegen”, the “Company), a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced today that Robert Newman has been appointed... - January 19, 2011 - MiTeGen, LLC
Ameridose Opens New State-of-the-Art Sterile Admixing Facility
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce the opening of its third and newest manufacturing facility. Located in Westborough, MA, the new 70,000 sq. ft. facility has been constructed using the finest building materials and contains state-of-the-art clean room equipment. - January 19, 2011 - Ameridose, LLC
Synpromics Appoints Andrei Lyne as CFO
Synpromics Ltd. is pleased to announce that Andrei Lyne has joined the company as Chief Financial Officer. The new appointment demonstrates Synpromics’s commitment to build a world-class management team to fully exploit the exciting potential of its innovative technology. - January 19, 2011 - Synpromics Ltd
GenScript Corporation Has Installed the First BiacoreTM T200 Biosensor in the World
GenScript Corporation and GE Healthcare Life Sciences China together held an opening ceremony on Dec 22nd 2010 in Nanjing China, to celebrate the successful installation of the first unit of BiacoreTM T200 instrument in the world. To an audience of primarily research scientists from both big... - January 19, 2011 - GenScript USA Inc.
Laboratory Robotics Interest Group (LRIG) Exhibits at LabAutomation
The Laboratory Robotics Interest Group (LRIG) is pleased to announce its participation in LabAutomation2011, January 29 - February 2, 2011, Palm Springs Convention Center, Palm Springs, California. All conferees, exhibitors, and media are invited to visit the LRIG booth, #492 to get the latest... - January 17, 2011 - Laboratory Robotics Interest Group (LRIG)
MedPro Rx, Inc. Introduces New Online Game to Help Children with Chronic Illness
Local Specialty Pharmacy Offers Memory Match on Kids Website. - January 16, 2011 - MedPro Rx, Inc.
Blue and Red Density Marker Beads Now Available from Cospheric LLC
Cospheric LLC, a microsphere manufacturing and distributing company, recently launched a line of density marker beads in particle size ranges from 10 micron to 600 micron in diameter. Two microsphere product lines having densities of 1.065 g/cc and 1.075 g/cc are currently in stock and ready for... - January 15, 2011 - Cospheric LLC
Bioo Scientific Launches a Sensitive ELISA for Detection of Melamine Contamination in Food
Today Bioo Scientific released the MaxSignal® Melamine ELISA Kit for the sensitive detection of melamine contamination in food samples including milk, milk powder, feed, meat and even chocolate. - January 14, 2011 - Bioo Scientific
BPA in Medical Devices - is This a Concern? Carmel Pharma's PhaSeal Closed-System Drug Transfer Device (CSTD) Does Not Contain BPA.
Bisphenol A (BPA) is a substance used to make common polycarbonate plastic. However, the growing global concern regarding the health effects of this substance has lead several countries and organizations to issue health warnings. BPA will be banned in the manufacture of baby bottles 2011 in the... - January 14, 2011 - Carmel Pharma
New Cancer Treatment Techniques Offer Hope to Patients Fighting Deadly Tumors
The Integrative Cancer Therapies Fellowship with the American Academy of Anti-Aging Medicine (A4M; www.worldhealth.net) announces that Dr. Mark Rosenberg, Medical Director of the Institute for Healthy Aging and Director of the Integrative Cancer Therapies Fellowship, will present preliminary findings of a novel technique for treating advanced-stage cancer. Dr. Rosenberg will be sharing his findings at the Fellowship in Integrative Cancer Therapies taking place March 10-13, 2011 in Boca Raton, FL - January 13, 2011 - A4M
This Valentine's Day, Go for the Sexy Scruff, Says MenScience
Research shows women like men with a little sexy scruff. MenScience has the products men need to be their sexiest. - January 13, 2011 - MenScience Androceuticals
Oncolytics Biotech® Inc. Announces Opening of Enrollment in U.S. Phase I Colorectal Cancer Study
The principal investigator of the new colon cancer trial using Reolysin is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York. - January 13, 2011 - Oncolytics Biotech
Pacific Biomarkers, Inc. Announces Awards of Major Research Contracts
Pacific Biomarkers, Inc. (OTCBB: PBMC, “PBI”), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced today that it has been awarded two major research contracts with two multinational pharmaceutical companies (the... - January 13, 2011 - Pacific Biomarkers Inc
NovaBay Pharmaceuticals Reports Activity of New Drug Against Deadly “Superbug”
NovaBay recently announced that in tests conducted at a third-party laboratory, its experimental drug NVC-422 showed in vitro activity against NDM-1. - January 13, 2011 - NovaBay Pharmaceuticals, Inc.
curasan Inc. and TransCorp Spine Inc. Sign Supply Agreement for the US-Market
curasan Inc., the north American subsidiary of exchange listed curasan AG, Germany, (ISIN: DE 000 549 453 8), has signed an exclusive supply agreement with TransCorp Spine Inc., Michigan, USA, for Cerasorb® Ortho block forms used to repair vertebral bone channels created during surgeries to... - January 13, 2011 - curasan AG
Study Proves Macular Health Dissolves Up to Five and a Half Times Faster Than Many Competing AMD Vitamin Supplements
According to a recent study, the Macular Health vitamin supplement dissolves up to five and a half times faster than other leading eye vitamin supplements. The study indicated that Macular Health, which slows the progression of vision loss due to age-related macular degeneration (AMD), dissolves in... - January 12, 2011 - Macular Health
CCC Diagnostis Inc. Launches Improved Test for Breast Cancer Treatment
CCC Diagnostics Inc has released the DirectHit Panel for Breast Cancer. DirectHit is a CLIA certified test, that accurately predicts the tumor’s response to four commonly prescribed classes of anti-cancer drugs. DirectHit allows a physician to personalize treatment plans for breast cancer patients. - January 12, 2011 - CCC Diagnostics LLC
New Medimix Asia Commercial Manager Brings Valuable Experience in Chinese Lifesciences Market
Medimix Asia announces the appointment of Jiayin He as Commercial Manager in its Shanghai office. Ms. He brings a comprehensive knowledge of the fields of biotechnology and chemistry, as well as medical research, license applications, and pharmaceutical sales in the Chinese hospital environment. This combined understanding of medical research and Chinese doctors’ behavior promises to offer invaluable insights to life science companies seeking to enter or expand in the Asian markets. - January 12, 2011 - Medimix International
MRSA Infected Mesh Successfully Treated with Triticum's L-Mesitran Honey Ointment
The overall reported percentage of mesh infections is 1.3%. Infections after incisional ventral hernia repair depend on many factors. Salvaging an infected mesh should be the priority, because serious complications are reported following mesh removal. Dr Chatzoulis et al. reports a case report and... - January 12, 2011 - Mesitran